ABSTRACT
Importance Perinatal exposures have been associated with autism spectrum disorder (ASD). It is unknown whether perinatal exposures are also associated with the burden of comorbidities in ASD across different medical domains.
Objective To examine the burden and pattern of comorbidities in individuals with ASD, and evaluate the associations between perinatal exposures linked with ASD and distinct comorbidities.
Design We used data from family-based study (SPARK) which recruited families with one or more children with a clinically confirmed ASD diagnosis across clinical sites throughout the US.
Setting All data in SPARK are collected remotely to allow participants to complete the study protocol at their convenience.
Participants To minimize recall bias of early-life exposures, we restricted the sample to individuals born between 1999 and 2019 who were less than 18 years of age at the time of registration into the study. The final analytic sample included 40,582 children with ASD and 11,389 non-ASD siblings.
Exposures Perinatal exposures including preterm birth, prenatal infection, fetal alcohol syndrome, hypoxia at birth, bleeding into the brain during delivery, lead poisoning, brain infections, and traumatic brain injury.
Main Outcomes and Measures Outcomes were based on parent report of professional diagnosis of neurological, cognitive, psychiatric, and physical disorders.
Results Children with ASD had a substantially higher prevalence of all comorbidities compared to their siblings without an ASD diagnosis (all p-values <0.05). ADHD was the most common comorbidity, affecting 1 in every 3 children with ASD. In logistic regression models adjusted for covariates (annual household income, father’s and mother’s education, parental ages at childbirth, year of birth, age of the child at evaluation, race, and ethnicity), different exposures were associated with distinct patterns of comorbidities in ASD cases, including associations between preterm birth and difficulty gaining weight (OR=2.38; 95%CI=2.09-2.71) and traumatic brain injury and seizure or epilepsy (OR=4.75; 95%CI=3.25-6.95). We observed a similar pattern of associations in non-ASD siblings.
Conclusions and Relevance Individuals with ASD experience a greater burden of perinatal exposures and comorbidities. The higher burden of comorbidities in this population could be partly attributable to the higher rates of perinatal exposures. Study findings, if replicated in other samples, can inform the etiology of comorbidity in ASD.
Question Does the pattern of comorbidities in individuals with autism spectrum disorder vary by pre- and postnatal exposures?
Findings The burden of pre- and postnatal exposures and comorbidity in children with autism spectrum disorder (ASD) is significantly higher than in their non-ASD siblings. Distinct pre- and postnatal exposures were associated with different patterns of comorbidities.
Meaning Children with ASD experience a significantly higher burden of comorbidities which may arise due to distinct etiological factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to acknowledge the generous support of the Beatrice and Samuel A. Seaver Foundation. VK was supported by National Institute of Mental Health Award T32 MH122394.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed by the institutional review board of the Icahn School of Medicine at Mount Sinai and received an exempt status.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study data (SPARK study database) are available upon reasonable request to the Simons Foundation Autism Research Initiative (SFARI).
